Appaloosa steps up pressure on Allergan after failed depression drug trials By Reuters

0
5
© Reuters. A sign marks Allergan


© Reuters. A sign marks Allergan’s offices in Medford

TedsWoodworking Plans and Projects

(Reuters) – Hedge fund Appaloosa LP on Thursday reiterated its call for an independent chairman at Allergan (NYSE:) Plc’s board, after the Botox-maker said its depression treatment failed three late-stage studies.

“With this latest fiasco, we again call on the Company to install an independent chairman with suitable experience to bring new leadership to the Board and rein in management’s predilection for value-destruction,” the hedge fund said.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.





Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here